AlphaCentric Advisors LLC 13F Holdings · Q3 2026
AlphaCentric Advisors LLC reported 245 securities worth $112.61M in its SEC 13F filing for Q3 2026 (period ended 2026-09-30). Top holdings: SHY (4.76%), GILD (2.82%), IWD (2.65%). Among its top 25 positions this quarter: 2 new, 21 added, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SHY | ISHARES TR | $5.4M | 4.76% | 66,011 | Added |
| 2 | GILD | GILEAD SCIENCES INC | $3.2M | 2.82% | 21,278 | Added |
| 3 | IWD | ISHARES TR | $3.0M | 2.65% | 12,020 | Added |
| 4 | RPV | INVESCO EXCHANGE TRADED FD T | $2.9M | 2.59% | 25,447 | Added |
| 5 | VRTX | VERTEX PHARMACEUTICALS INC | $2.7M | 2.37% | 5,115 | Added |
| 6 | INVH | INVITATION HOMES INC | $1.9M | 1.71% | 73,000 | Hold |
| 7 | AZN | ASTRAZENECA PLC | $1.9M | 1.70% | 11,866 | Added |
| 8 | ROIV | ROIVANT SCIENCES LTD | $1.8M | 1.64% | 50,535 | Added |
| 9 | INCY | INCYTE CORP | $1.8M | 1.63% | 15,140 | Added |
| 10 | ARGX | ARGENX SE | $1.8M | 1.57% | 1,841 | Added |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.5M | 1.29% | 10,230 | Added |
| 12 | INSM | INSMED INC | $1.4M | 1.24% | 12,195 | Added |
| 13 | EEFT | EURONET WORLDWIDE INC | $1.4M | 1.20% | 21,560 | Added |
| 14 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.4M | 1.20% | 9,616 | Added |
| 15 | PINE | ALPINE INCOME PPTY TR INC | $1.3M | 1.16% | 75,000 | New |
| 16 | BLDR | BUILDERS FIRSTSOURCE INC | $1.3M | 1.14% | 22,500 | Added |
| 17 | AXSM | AXSOME THERAPEUTICS INC. | $1.2M | 1.11% | 6,752 | Added |
| 18 | HALO | HALOZYME THERAPEUTICS INC | $1.1M | 0.96% | 9,821 | Added |
| 19 | JAZZ | JAZZ PHARMACEUTICALS PLC | $1.1M | 0.96% | 4,688 | Added |
| 20 | ASND | ASCENDIS PHARMA A/S | $1.1M | 0.95% | 4,706 | Added |
| 21 | AMGN | AMGEN INC | $1.0M | 0.92% | 2,455 | Added |
| 22 | CTO | CTO RLTY GROWTH INC NEW | $1.0M | 0.91% | 50,000 | Added |
| 23 | UMAC | UNUSUAL MACHS INC | $979,200 | 0.87% | 40,000 | Trimmed |
| 24 | ABBV | ABBVIE INC | $963,436 | 0.86% | 3,683 | Added |
| 25 | IYR | ISHARES TR | $950,400 | 0.84% | 10,000 | New |
Source: SEC Form 13F filings · as of 2026-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR